Recce Pharmaceuticals (FRA:R9Q) Total Deposits

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R9Q Recce Pharmaceuticals Ltd FRA:R9Q
20 GF Score
Price €0.18
! 5 Warning Signs
View Full Analysis

What is Recce Pharmaceuticals Total Deposits?

Total Deposits only applies to banks.

FRA:R9Q
20GF Score
Recce Pharmaceuticals Ltd FRA:R9Q
Total Deposits is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recce Pharmaceuticals Business Description

Other Exchanges RCE:Australia
Address 1 Farrer Place, Level 15, Governor Macquarie Tower, Sydney, NSW, AUS, 2000
Recce Pharmaceuticals Ltd is an Australian clinical-stage biotechnology company developing a new class of synthetic anti-infectives designed to address antibiotic-resistant bacteria and emerging viral pathogens. Its lead candidate, RECCE 327, is being developed as an intravenous therapy for serious and life-threatening bacterial infections, including sepsis and infections caused by Escherichia coli, while other candidates target topical and oral applications. The company's compounds are intended to offer broad-spectrum activity with a low likelihood of inducing resistance. Recce operates as a single research and development segment, conducting preclinical studies and clinical trials rather than selling commercial products, so it generates no meaningful product revenue and funds operations through equity raisings and government grants. Its activities and listings span Australia, the United Kingdom and the United States, with its primary operations and corporate base in Australia.
20GF Score

Get the complete analysis for FRA:R9Q

Total Deposits is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price